
|Articles|September 9, 2016
Resurgence of penicillin-susceptible isolates
Watch as Regis Kowalski, Executive Director, The Charles T. Campbell Laboratory at the University of Pittsburgh, explains how newly discovered resurgent isolates may affect clinical practice.
Advertisement
Watch as Regis Kowalski, Executive Director, The Charles T. Campbell Laboratory at the University of Pittsburgh, explains how newly discovered resurgent isolates may affect clinical practice.
Related articles:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5





















